4/ May29 @sanofi announced it was halting recruitment for its international, multi-country, quadruple-blinded RCT of #HCQ for EARLY out-patient treatment of #COVID19, citing WHO’s then cardiac concerns based on the now retracted fake #LancetGate “study”
▶️business.financialpost.com/pmn/business-p…
5/ After #LancetGate exposed by brave voices in medical community 🌎, WHO announced on Jun3 that it was resuming its “Solidarity” #HCQ clinical trials. Jun3: #Sanofi announced it would be holding “consultations” to decide whether to restart its HCQ RCT. ⬇️
mobile.reuters.com/article/amp/id…
6/ On June 4, the fake #LancetGate #HCQ “study” was officially retracted by 3 of its authors from the disgraced Lancet. On June 4, #Sanofi updated its trial record on the intl clinicaltrials website announcing it had suspended its international HCQ RCT ⬇️
clinicaltrials.gov/ct2/show/NCT04…
7/ Why has @sanofi not resumed its #HCQ RCT? Fake #LancetGate “study” it based its decision to suspend RCT was retracted. Even WHO has reversed its decision. Published studies, case-controlled trials & RCTs show NO #HCQ cardiac toxicity in #COVID19 pts, even at very high doses.
8/ #HCQ=cheap, safe, generic med. #Sanofi has tiny market w/Plaquenil. But in Apr “Sanofi CEO Paul Hudson pointed out that his company is 1 of v few..able to manufacture any #SARSCoV2 vaccine at scale req to satisfy what is certain to be immense🌎demand”
▶️nasdaq.com/articles/sanof…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.